Category Archives: Uncategorized

08 Jan

Quick Ways to Make Your Google Ads Stand Out from the Competition

Google Ads amounts to billions of dollars in revenue for the search engine giant, but what about your revenue? Standing

08 Jan

Alector Files for IPO to Fund Studies of Alzheimer’s, Dementia Drugs

Alector, a biotech company focusing on the immune system to treat degenerative brain disorders such as Alzheimer’s disease, has filed

08 Jan

Autonomous Vehicles Summit – 30-31 May 2019, Bratislava, Slovakia

[Source: Research & Innovation] AUTONOMOUS VEHICLES SUMMIT The biggest event of AVs in CEE The first year of the two-days

08 Jan

Despite Administration’s “Sky-High Rhetoric,” Importing Foreign Price Controls Will Harm Innovation and Patient Access

In October of 2018, the Trump Administration outlined a proposal that would import foreign price controls for medicines covered under

07 Jan

Bio-JPM Roundup: Lilly Buys Loxo, Sage’s Stock Soars, ALS Cash & More

The flow of biotech news is particularly heavy today, and for good reason. The annual J.P. Morgan Healthcare Conference, one

07 Jan

Autonomous Vehicles Summit – 30-31 May 2019, Bratislava, Slovakia

[Source: Research & Innovation] AUTONOMOUS VEHICLES SUMMIT The biggest event of AVs in CEE The first year of the two-days

07 Jan

Despite Administration’s “Sky-High Rhetoric,” Importing Foreign Price Controls Will Harm Innovation and Patient Access

In October of 2018, the Trump Administration outlined a proposal that would import foreign price controls for medicines covered under

07 Jan

Poseida Therapeutics Prepares for IPO to Advance CAR-T Treatments

Poseida Therapeutics, which is testing CAR-T cell therapies for blood-borne and solid tumor cancers, has laid the groundwork for an

07 Jan

4 Facts About Using Genetics in Pursuit of a More Perfect Christmas Tree

What will your Christmas gifts be placed under this year? A Fraser fir? A Douglas fir? An artificial tree? While

06 Jan

Poseida Therapeutics Prepares for IPO to Advance CAR-T Treatments

Poseida Therapeutics, which is testing CAR-T cell therapies for blood-borne and solid tumor cancers, has laid the groundwork for an